Return to search

The Efficacy of Biofeedback and Its Use Towards ADHD

Attention deficit hyperactivity disorder (ADHD) is a psychopathology commonly characterized by general inattentiveness and/or a lack of impulse control resulting in hyperactive tendencies. ADHD is estimated to cost the United States roughly $266 billion every year. ADHD is currently treated via medications, cognitive behavioral therapy, or more recently, neurofeedback. Neurofeedback – and biofeedback in general – is the process of providing a patient with information about autonomic bodily functions so that they may control said autonomic function. In the case of ADHD, neurofeedback focuses on reinforcing the behaviors and sensations associated with attentiveness. Currently however, neurofeedback systems are large and require a patient to travel to a clinic. Furthermore, the current offering of portable neuro/biofeedback devices do not have the technological capabilities to provide effective neurofeedback therapy. Current wearable tech devices – such as the Apple Watch and Samsung Gear – possess the technological capabilities to measure important bodily functions, and provide appropriate biofeedback therapy while remaining discrete and most importantly, portable.

Identiferoai:union.ndltd.org:CLAREMONT/oai:scholarship.claremont.edu:cmc_theses-2515
Date01 January 2017
CreatorsBieganski, Darius Witold
PublisherScholarship @ Claremont
Source SetsClaremont Colleges
Detected LanguageEnglish
Typetext
Formatapplication/pdf
SourceCMC Senior Theses
Rights© 2016 Darius W Bieganski, default

Page generated in 0.0018 seconds